BSE - Delayed Quote INR

Morepen Laboratories Limited (MOREPENLAB.BO)

Compare
68.22
-2.66
(-3.75%)
At close: January 10 at 3:58:45 PM GMT+5:30
Loading Chart for MOREPENLAB.BO
DELL
  • Previous Close 70.88
  • Open 71.00
  • Bid 68.22 x --
  • Ask 68.40 x --
  • Day's Range 67.79 - 71.18
  • 52 Week Range 38.56 - 100.80
  • Volume 435,947
  • Avg. Volume 737,839
  • Market Cap (intraday) 37.381B
  • Beta (5Y Monthly) 1.49
  • PE Ratio (TTM) 26.96
  • EPS (TTM) 2.53
  • Earnings Date Jan 29, 2025 - Feb 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 18, 2002
  • 1y Target Est --

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

www.morepen.com

2,152

Full Time Employees

March 31

Fiscal Year Ends

Recent News: MOREPENLAB.BO

View More

Performance Overview: MOREPENLAB.BO

Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

MOREPENLAB.BO
9.82%
S&P BSE SENSEX
1.11%

1-Year Return

MOREPENLAB.BO
34.40%
S&P BSE SENSEX
8.39%

3-Year Return

MOREPENLAB.BO
20.53%
S&P BSE SENSEX
29.52%

5-Year Return

MOREPENLAB.BO
340.13%
S&P BSE SENSEX
86.67%

Compare To: MOREPENLAB.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MOREPENLAB.BO

View More

Valuation Measures

As of 1/10/2025
  • Market Cap

    37.38B

  • Enterprise Value

    35.67B

  • Trailing P/E

    26.96

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.02

  • Price/Book (mrq)

    3.37

  • Enterprise Value/Revenue

    2.04

  • Enterprise Value/EBITDA

    16.88

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.40%

  • Return on Assets (ttm)

    8.31%

  • Return on Equity (ttm)

    13.88%

  • Revenue (ttm)

    17.75B

  • Net Income Avi to Common (ttm)

    1.31B

  • Diluted EPS (ttm)

    2.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.86B

  • Total Debt/Equity (mrq)

    3.02%

  • Levered Free Cash Flow (ttm)

    -669.34M

Research Analysis: MOREPENLAB.BO

View More

People Also Watch